The Parainfluenza Virus Infection market is expected to surge due to the disease's increasing prevalence and awareness during ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

Hospitalized parainfluenza and influenza infections in particular remain a major unmet medical need. Ansun BioPharma has taken a unique approach to developing an antiviral to treat severe ...

Just weeks after a government official urged Brits to don masks once more, a worrying rise in adenovirus, HMPV, parainfluenza and rhinovirus have all now been seen. Dr Conall Watson, Consultant ...

--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune ...